Larger Text
Smaller TextPeter Powers,
MD, FRCPC
Associate Professor
Pathology and Molecular Medicine
Division: Clinical Pathology
St. Joseph's Hospital
L208-2 St. Luke's Wing
Hamilton, Ontario
905-521-6024
ppowers@stjoes.ca
Faculty Biography
Education and Professional Standing
FRCPC Internal Medicine, 1977
FRCPC Haematology, 1975
MD, University of Saskatchewan, 1971
BA Chemistry, 1967
Interests
As a Clinical Haematologist, Dr. Powers provides service through the Hamilton Regional Laboratory Medicine Program. He is also actively involved in the Undergraduate (M.D.) and Postgraduate Medicine Educational Programs.
Dr. Power's research interests include the diagnosis, prevention and treatment of venous thromboembolism.
Selected Publications
Waye JS, Eng B, Chui DH, Powers PJ, Lafferty JD. Second report of Hb Toulon [alpha77(EF6)Pro-->His] in a Canadian family of Italian descent. Hemoglobin. 2000 Nov;24(4):359-60.
Gent M, Hirsh J, Ginsberg JS, Powers PJ, Levine MN, Geerts WH, Jay RM, Leclerc J, Neemeh JA, Turpie AG. Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Circulation. 1996 Jan 1;93(1):80-4.
Turpie AG, Gent M, Cote R, Levine MN, Ginsberg JS, Powers PJ, Leclerc J, Geerts W, Jay R, Neemeh J, et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med. 1992 Sep 1;117(5):353-7.
